AU6376700A - Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy - Google Patents

Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy

Info

Publication number
AU6376700A
AU6376700A AU63767/00A AU6376700A AU6376700A AU 6376700 A AU6376700 A AU 6376700A AU 63767/00 A AU63767/00 A AU 63767/00A AU 6376700 A AU6376700 A AU 6376700A AU 6376700 A AU6376700 A AU 6376700A
Authority
AU
Australia
Prior art keywords
immuno
methotrexate
interleukin
combined use
modulatory therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU63767/00A
Inventor
Paul C. Grint
Satwant K Narula
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU6376700A publication Critical patent/AU6376700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU63767/00A 1999-07-28 2000-07-26 Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy Abandoned AU6376700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36215699A 1999-07-28 1999-07-28
US09362156 1999-07-28
PCT/US2000/020304 WO2001008696A2 (en) 1999-07-28 2000-07-26 Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy

Publications (1)

Publication Number Publication Date
AU6376700A true AU6376700A (en) 2001-02-19

Family

ID=23424910

Family Applications (1)

Application Number Title Priority Date Filing Date
AU63767/00A Abandoned AU6376700A (en) 1999-07-28 2000-07-26 Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy

Country Status (2)

Country Link
AU (1) AU6376700A (en)
WO (1) WO2001008696A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112755191A (en) * 2021-01-20 2021-05-07 安徽医科大学第一附属医院 Application of CaMK4 in preparation of medicine for preventing and treating psoriasis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018783A1 (en) * 1992-03-20 1993-09-30 Schering Corporation Use of interleukin-10 to induce the production of interleukin-1 receptor antagonist
US6270766B1 (en) * 1992-10-08 2001-08-07 The Kennedy Institute Of Rheumatology Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
US5753218A (en) * 1996-05-03 1998-05-19 Schering Corporation Method for treating inflammation
WO1998024477A1 (en) * 1996-12-06 1998-06-11 Amgen Inc. Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases

Also Published As

Publication number Publication date
WO2001008696A3 (en) 2001-08-30
WO2001008696A2 (en) 2001-02-08

Similar Documents

Publication Publication Date Title
AU1041599A (en) Therapeutic uses of triazolo-pyridazine derivatives
AU9128798A (en) Genotyping of human cyp3a4
AU1403199A (en) Local delivery of therapeutic agents
MXPA02004770A (en) Therapeutic compositions and methods of use thereof.
AU2002219229A1 (en) Means for the diagnosis and therapy of CTCL
EP1073416A4 (en) Use of inhaled no as anti-inflammatory agent
AU6935498A (en) Novel phosphate compounds and their use as medicaments
AU7757400A (en) Antiviral therapy use of p-glycoprotein modulators
AU3766700A (en) Human tumor necrosis factor receptor-like 2
AU6450398A (en) Sr-bi regulatory sequences and therapeutic methods of use
AU3630695A (en) Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU7410900A (en) Alginate preparation and use of the same
AU6376700A (en) Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy
AU4629399A (en) Substituted piperazones and their therapeutic uses
AU7920198A (en) Intratumoral administration of triphenylethylenes for the treatment of cancer
AU2002218977A1 (en) Novel marker for the diagnosis and therapy of tumours
AU6084598A (en) Antibiotic-ligand conjugates and methods of use thereof
AU7641098A (en) Therapeutic composition
AU8049098A (en) Composition and methods for the treatment of inflammatory diseases
AU1801297A (en) Spiro-ketal derivatives and their use as therapeutic agents
AU1579700A (en) Cytokine combination therapy
AU1037301A (en) Therapy of cephalic pain
AU1711599A (en) Prodrugs of lobucavir and methods of use
AU3423397A (en) Therapeutic methods and compositions for use therein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase